Neoadjuvant treatment for rectal cancer-A value-based proposition. - Wikidata - wikimedia - TriplyDB

Neoadjuvant treatment for rectal cancer-A value-based proposition.

Neoadjuvant treatment for rectal cancer-A value-based proposition.

http://www.wikidata.org/entity/Q30251516

about

Controversies in the multimodality management of locally advanced rectal cancer.

P2860

Q38691264-5A0E6939-B2BE-45DA-A1D8-D35626FBAFA8

P2860

Neoadjuvant treatment for rectal cancer-A value-based proposition.

http://www.wikidata.org/entity/Q30251516

description

2016 nî lūn-bûn

@nan

2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Neoadjuvant treatment for rectal cancer-A value-based proposition.

@ast

Neoadjuvant treatment for rectal cancer-A value-based proposition.

@en

type

label

Neoadjuvant treatment for rectal cancer-A value-based proposition.

@ast

Neoadjuvant treatment for rectal cancer-A value-based proposition.

@en

prefLabel

Neoadjuvant treatment for rectal cancer-A value-based proposition.

@ast

Neoadjuvant treatment for rectal cancer-A value-based proposition.

@en

P1433

Q30251516-6E17482C-564F-4537-B54F-82738F167242

P1476

Q30251516-96C293E5-AF8E-4709-A6E1-237B3D33F3A1

P2093

Q30251516-4122E783-3012-4796-AA72-A5CF23C936BA

Q30251516-864492E3-1C94-4B6E-910C-59DB3BC2403A

P2860

Q30251516-0B26F8A8-4299-4605-AA5D-946F274719B9

Q30251516-0C2AFB74-84A3-408A-815E-67B95DF69536

Q30251516-100311A8-283B-44C1-9AE3-5ED4756058C1

Q30251516-17C34F7E-B642-447E-976D-4DE2E14B8139

Q30251516-2706663C-483B-4581-A88F-1CB80C5527BC

Q30251516-3EBE6FEF-5CC8-4B4B-A466-11A0A3BF99FA

Q30251516-3F4F5053-2B87-456B-8AF5-F87F39952236

Q30251516-40D536F4-1445-4ED5-B286-66AA2A56A19F

Q30251516-41FCF35E-F533-4A2A-9FB0-A8AC5401672E

Q30251516-430056A1-896C-4D5C-9867-9DD71D8D555C

P304

Q30251516-2B5A02F8-129F-48E2-AE04-6D20677627DE

P31

Q30251516-3A19E9F7-8E1A-4BBF-B0C7-A5829AD0F7DB

P356

Q30251516-7C20A629-CA63-42E9-87FD-1C9C33A33687

P433

Q30251516-799332FF-6B61-47EB-8319-26C66A3CC026

P478

Q30251516-02EA731F-DD08-4D85-92F4-1505CD297B04

P50

Q30251516-71BBF155-35B7-4A8D-BCA2-7453827FD48F

P577

Q30251516-AC322A18-BB42-4C27-8ACC-BEA34232F8C4

P698

Q30251516-BA45C17F-8E70-4A02-B52C-9A75459015BE

P356

P1433

Journal of Surgical Oncology

P1476

Neoadjuvant treatment for rectal cancer-A value-based proposition.

@en

P2093

Avo Artinyan

http://www.w3.org/2001/XMLSchema#string

George J Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer treatment and survivorship statistics, 2014

Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and

Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data.

Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial.

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.

Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer.

Impact of short-course preoperative radiotherapy for rectal cancer on patients' quality of life: data from the Medical Research Council CR07/National Cancer Institute of Canada Clinical Trials Group C016 randomized clinical trial.

Impact of ileostomy-related complications on the multidisciplinary treatment of rectal cancer.

Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery

OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer.

P304

304-310

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.24267

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P50

Nader N Massarweh

P577

2016-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27111410

http://www.w3.org/2001/XMLSchema#string